search
Back to results

Scaling up TB and HIV Treatment Integration (SUTHI)

Primary Purpose

HIV, Tuberculosis

Status
Completed
Phase
Not Applicable
Locations
South Africa
Study Type
Interventional
Intervention
Quality Improvement Model of Care
Sponsored by
Centre for the AIDS Programme of Research in South Africa
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for HIV

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • South African Department of Health Primary Health Care Clinics
  • ART site
  • Supported by BroadReach Healthcare

Exclusion Criteria:

  • Mobile clinics
  • Clinics that do not offer ART
  • Clinics with only 1 nurse
  • Hospitals and Gateway clinics

Sites / Locations

  • CAPRISA eThekwini Clinical Research Site

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

No Intervention

Arm Label

Quality Improvement Intervention

Control Standard of Care

Arm Description

In intervention clinics, staff will follow QI methodology to undertake a detailed assessment of their HIV-TB care and to prioritize the steps to improve treatment outcomes. A senior nurse will be identified to be the QI champion and will be trained by the study team to fulfil this role. The QI champion in the clinic then provides peer-leadership, mentorship and support for the implementation of the prioritized changes until the checklist is complete and all integrated HIV-TB service components meet the required standard.

The control arm will continue with the usual support that is received for HIV-TB service integration

Outcomes

Primary Outcome Measures

Mortality
Mortality rate in TB-HIV co-infected patients

Secondary Outcome Measures

HIV testing rates
HIV testing rates in TB patients
Intensified Case Finding for TB
TB Screening in HIV infected patients
Cotrimoxazole for HIV-TB patients
Initiating Cotrimoxazole in HIV-TB patients
Retention in HIV-TB patients
Enhanced retention in care strategies including the use of community care workers for retention and for community based management of selected patients
ART initiation in HIV-TB co-infected patients
Initiating ART in co-infected patients irrespective of CD4 count
Integrated Data Management System
1 data management system for co-infected patients , including 1 file , 1 appointment and 1 health care worker addressing both HIV and TB care and treatment
HIV and TB Adherence Strategy
• Enhanced ART and TB treatment adherence strategies including the use of community care workers for adherence support and for community based management of selected patients

Full Information

First Posted
January 11, 2016
Last Updated
January 29, 2021
Sponsor
Centre for the AIDS Programme of Research in South Africa
Collaborators
BroadReach Health Care, Institute for Healthcare Improvement
search

1. Study Identification

Unique Protocol Identification Number
NCT02654613
Brief Title
Scaling up TB and HIV Treatment Integration
Acronym
SUTHI
Official Title
Addressing Challenges in Scaling up TB and HIV Treatment Integration in Public Health Settings in South Africa
Study Type
Interventional

2. Study Status

Record Verification Date
January 2021
Overall Recruitment Status
Completed
Study Start Date
June 1, 2015 (Actual)
Primary Completion Date
December 30, 2020 (Actual)
Study Completion Date
December 30, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Centre for the AIDS Programme of Research in South Africa
Collaborators
BroadReach Health Care, Institute for Healthcare Improvement

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study addresses the highest ranking health research priority in South Africa, which is, to develop and test optimal models of HIV-TB service delivery that will enhance retention, adherence and coverage of HIV-TB co-infected patients. HIV and TB are highest in sub-Saharan Africa, a region with limited health budgets, infrastructure, human resources, and suboptimal TB infection control practices. There is compelling clinical evidence suggesting that integrating HIV and TB services saves lives and presents an effective and efficient use of resources directed at optimizing health outcomes. Quality improvement (QI) methods are increasingly being used to systematically test and incorporate local ideas into strategies for reliable implementation and scale up. This trial is designed to test a practical, implementable and affordable strategy aimed at improving HIV-TB service integration to reduce TB and HIV associated deaths. This is a cluster randomized controlled trial, which evaluates and tests the effectiveness of implementing a QI model to integrate HIV-TB service delivery in primary health care clinics, on reducing morbidity and mortality in TB-HIV co-infected patients. This study will be conducted in 2 districts, Ugu and uThungulu, in KwaZulu-Natal, South Africa. The model of integrated care delivery for TB and HIV using the QI method offers a systems approach to care delivery to directly enhance treatment outcomes by enabling comprehensive effective care designed around the patients journey from entry to the clinic, through screening treatment initiation, treatment completion, and retention in care that is directed at the goals of cure for TB, effective sustainable HIV viral suppression and reduced HIV associated TB mortality as the main health impact. The scalability of the model, once proven effective, is the critical element that makes it increase population coverage of quality diagnosis and treatment of HIV-TB co-infection. QI methods promote front line staff engagement in identification and rapid testing of local implementation solutions to gaps in performance of processes of care along the steps of the patient journey. Gaps in care are identified through continuous feedback on a core set of indicators collected monthly as routine collection of data.
Detailed Description
The primary aim of this study is to test the effectiveness of a peer mentor-led, quality-improvement model of service delivery of integrated HIV-TB treatment on mortality in HIV-TB co-infected patients treated in rural primary health care clinics in KwaZulu-Natal, South Africa Specific Objectives (i) To determine the impact of a QI-mediated HIV-TB service integration on patient mortality. All patients that access services in intervention and control clinics, via either the TB entry point or via the HIV entry point will be tracked during clinic follow-up visits or, through a community care giver, and will have their vital status ascertained 12 months after clinic randomization. (ii) To determine the effectiveness of peer-led Quality Improvement (QI) to integrate HIV-TB services. The effect, on HIV-TB integrated processes of care, of the deployment of a QI approach (systems view, data driven decision making, culture of continuous improvement, trained peer mentors) to ensure uniform implementation of an essential package of evidence based HIV-TB interventions that support HIV-TB integration. The impact on clinical outcomes of using QI methods to implement integrated HIV and TB management will be assessed using the following indicators: Time to ART initiation among HIV infected TB suspects and cases; HIV testing rates in TB patients; Number of HIV-TB co-infected patients receiving co-treatment for TB and HIV at the same facility; Number of patients infected with HIV or TB that are retained in care at 12 months; Indicators of treatment adherence such as - number of HIV patients that are virologically suppressed at 12 months and TB treatment outcomes; Hospitalisation rates among patients receiving co-treatment for TB and HIV. (iii) To identify clinic-level factors that impact on integrated HIV-TB services. Understanding the context (environmental, social and political factors) in which we are working is essential to identifying factors that promote or inhibit the implementation of the intervention. We will use the COACH tool (Context Assessment for Community Health) [8] to collect data and assess the organizational context and the influence of factors such as organizational culture, leadership, resources and HCWs remuneration etc. on the intervention (iv) To determine the cost-effectiveness of implementing HIV-TB services using Quality Improvement methodology (Intervention Clinics) versus the base-case of implementing HIV-TB services independently, through a within-trial approach using both health service (e.g. training, remuneration) and patient costs (e.g. travel, opportunity costs) as inputs. We will also calculate total intervention costs to assess its affordability and explore cost-effectiveness under various scenarios (e.g. different TB-HIV co-infection rates) using decision analytical modeling. (v) To identify a set of interventions, change ideas, tools and approaches that can be used to scale up adoption, implementation and sustainability of integrated HIV-TB services across South Africa and in other resource constrained settings. (vi) To strengthen the capacity of CAPRISA to independently perform implementation research in PRDs, including community-randomized trials and health economic analysis, through expert mentoring and supervision of PhD programmes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV, Tuberculosis

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
8000 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Quality Improvement Intervention
Arm Type
Active Comparator
Arm Description
In intervention clinics, staff will follow QI methodology to undertake a detailed assessment of their HIV-TB care and to prioritize the steps to improve treatment outcomes. A senior nurse will be identified to be the QI champion and will be trained by the study team to fulfil this role. The QI champion in the clinic then provides peer-leadership, mentorship and support for the implementation of the prioritized changes until the checklist is complete and all integrated HIV-TB service components meet the required standard.
Arm Title
Control Standard of Care
Arm Type
No Intervention
Arm Description
The control arm will continue with the usual support that is received for HIV-TB service integration
Intervention Type
Other
Intervention Name(s)
Quality Improvement Model of Care
Intervention Description
QI addresses the "how" of program implementation. Technically, QI improves process performance by developing a common simplified view of the components and linkages of integrated care, real-time data feed-back to track system performance, understanding the psychology of system change, and crucially, the iterative testing and incorporation of ideas for performance improvement from the front-line practitioners, managers, and customers in the local context.
Primary Outcome Measure Information:
Title
Mortality
Description
Mortality rate in TB-HIV co-infected patients
Time Frame
12 months
Secondary Outcome Measure Information:
Title
HIV testing rates
Description
HIV testing rates in TB patients
Time Frame
12 months
Title
Intensified Case Finding for TB
Description
TB Screening in HIV infected patients
Time Frame
12 Months
Title
Cotrimoxazole for HIV-TB patients
Description
Initiating Cotrimoxazole in HIV-TB patients
Time Frame
12 months
Title
Retention in HIV-TB patients
Description
Enhanced retention in care strategies including the use of community care workers for retention and for community based management of selected patients
Time Frame
12 months
Title
ART initiation in HIV-TB co-infected patients
Description
Initiating ART in co-infected patients irrespective of CD4 count
Time Frame
12 months
Title
Integrated Data Management System
Description
1 data management system for co-infected patients , including 1 file , 1 appointment and 1 health care worker addressing both HIV and TB care and treatment
Time Frame
12 months
Title
HIV and TB Adherence Strategy
Description
• Enhanced ART and TB treatment adherence strategies including the use of community care workers for adherence support and for community based management of selected patients
Time Frame
12 months

10. Eligibility

Sex
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: South African Department of Health Primary Health Care Clinics ART site Supported by BroadReach Healthcare Exclusion Criteria: Mobile clinics Clinics that do not offer ART Clinics with only 1 nurse Hospitals and Gateway clinics
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kogieleum Naidoo, MBChB
Organizational Affiliation
Centre for the AIDS Programme of Research in South Africa
Official's Role
Principal Investigator
Facility Information:
Facility Name
CAPRISA eThekwini Clinical Research Site
City
Durban
State/Province
KwaZulu Natal
ZIP/Postal Code
4001
Country
South Africa

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
35198922
Citation
Naidoo K, Gengiah S, Yende-Zuma N, Mlobeli R, Ngozo J, Memela N, Padayatchi N, Barker P, Nunn A, Karim SSA. Mortality in HIV and tuberculosis patients following implementation of integrated HIV-TB treatment: Results from an open-label cluster-randomized trial. EClinicalMedicine. 2022 Feb 12;44:101298. doi: 10.1016/j.eclinm.2022.101298. eCollection 2022 Feb.
Results Reference
derived
PubMed Identifier
34535170
Citation
Gengiah S, Connolly C, Yende-Zuma N, Barker PM, Nunn AJ, Padayatchi N, Taylor M, Loveday M, Naidoo K. Organizational contextual factors that predict success of a quality improvement collaborative approach to enhance integrated HIV-tuberculosis services: a sub-study of the Scaling up TB/HIV Integration trial. Implement Sci. 2021 Sep 17;16(1):88. doi: 10.1186/s13012-021-01155-7.
Results Reference
derived
PubMed Identifier
34498370
Citation
Gengiah S, Barker PM, Yende-Zuma N, Mbatha M, Naidoo S, Taylor M, Loveday M, Mhlongo M, Jackson C, Nunn AJ, Padayatchi N, Karim SSA, Naidoo K. A cluster-randomized controlled trial to improve the quality of integrated HIV-tuberculosis services in primary healthcareclinics in South Africa. J Int AIDS Soc. 2021 Sep;24(9):e25803. doi: 10.1002/jia2.25803.
Results Reference
derived
PubMed Identifier
29132380
Citation
Naidoo K, Gengiah S, Yende-Zuma N, Padayatchi N, Barker P, Nunn A, Subrayen P, Abdool Karim SS. Addressing challenges in scaling up TB and HIV treatment integration in rural primary healthcare clinics in South Africa (SUTHI): a cluster randomized controlled trial protocol. Implement Sci. 2017 Nov 13;12(1):129. doi: 10.1186/s13012-017-0661-1. Erratum In: Implement Sci. 2019 Jun 13;14(1):59.
Results Reference
derived

Learn more about this trial

Scaling up TB and HIV Treatment Integration

We'll reach out to this number within 24 hrs